Navigation Links
WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
Date:12/10/2008

Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at www.wellpoint.com .


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dr. Charles Kennedy, Vice President of Health Information Technology for WellPoint, Inc., to Present Today at The 4th Annual World Healthcare Innovation and Technology Congress (WHIT v.4.0)
2. WellPoint Announces Second Annual Innovation Event
3. WellPoint Congratulates President-Elect Barack Obama
4. WellPoint Awarded Prestigious International Marketing Award
5. WellPoint President and CEO Angela Braly Appears at the Norfolk Forum
6. WellPoint Announces Appearances at Upcoming Conferences
7. WellPoint Reports Third Quarter 2008 Results
8. WellPoints Dr. Alan Rosenberg to Address Industrys Top Medical Technology Conference
9. WellPoint Adjusts Health and Pharmacy Guidelines for Members in Texas and Louisiana Affected by Hurricane Ike
10. WellPoint Announces Appointments of Lori Beer as Executive Vice President and Chief Information Officer; Martin Miller as Senior Vice President, Chief Accounting Officer and Controller
11. WellPoint Appoints Krista A. Bowers as President of Senior Business
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3The YogaForce A Line Mat Provides The Perfect Solution For Fitness Needs 62204 1The YogaForce A Line Mat Provides The Perfect Solution For Fitness Needs 62204 2The YogaForce A Line Mat Provides The Perfect Solution For Fitness Needs 62204 3New Study Finds Men and Women May Respond Differently to Danger 6558 1New Study Finds Men and Women May Respond Differently to Danger 6558 2New Study Finds Men and Women May Respond Differently to Danger 6558 3Siemens Introduces Its New Power Couple at RSNA 2009 6557 1Siemens Introduces Its New Power Couple at RSNA 2009 6557 2Siemens Introduces Its New Power Couple at RSNA 2009 6557 3Siemens Introduces Its New Power Couple at RSNA 2009 6557 4Siemens Introduces Its New Power Couple at RSNA 2009 6557 5Siemens Introduces Its New Power Couple at RSNA 2009 6557 6Siemens Introduces Its New Power Couple at RSNA 2009 6557 7